Skip to main content
Red Light Holland Corp. logo

Red Light Holland Corp. — Investor Relations & Filings

Ticker · TRIP ISIN · CA75671E1097 LEI · 529900C4CDMRMMH35G80 CSE Agriculture, forestry and fishing
Open in API
Filings indexed 313 across all filing types
Latest filing 2026-04-01 Regulatory Filings
Country CA Canada
Listing CSE TRIP

About Red Light Holland Corp.

https://redlight.co/

Red Light Holland Corp. is engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits, and psilocybin truffles across North America and Europe. The company supplies premium, recreational-grade magic truffles, primarily under the iMicrodose brand, to the legal adult-use market in the Netherlands. Through its applied science platform, Scarlette Lillie Science and Innovation, the company holds licenses for the research, cultivation, and extraction of various psychedelic and plant-based compounds, including psilocybin, for medicinal and scientific purposes. A key focus is the development of naturally occurring, non-synthetic "whole fungi" psilocybin medicine for future medical markets.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a news release announcing Red Light Holland’s support for a clinical research study through a partnership with Filament Health. It is not a financial results announcement (no earnings or balance sheet data), nor governance, management changes, dividends, or other specialized disclosures. It reads as a general corporate news update with forward-looking statements, typical of press releases filed under general regulatory announcements. Therefore, it falls into the fallback category “Regulatory Filings (RNS).”
2026-04-01 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release from Red Light Holland announcing a operational milestone (a 5kg psilocybin shipment) and a corporate action (issuance of shares for debt settlement). While it contains a share issuance, the primary purpose is a general corporate update/announcement. Since it does not fit into specific categories like 10-K, ER, or DIRS, and is a general regulatory announcement, it is classified as RNS.
2025-11-19 English
Material change report - English.pdf
Regulatory Filings Classification · 1% confidence The document is a 'Material Change Report' (Form 51-102F3), which is a standard Canadian regulatory filing used to disclose significant events such as business expansions, equity grants, and share issuances for debt. While it contains information about director dealings and share issuances, the document is a formal regulatory disclosure of material changes rather than a standalone director dealing report or a simple share issuance announcement. Given the 'Regulatory Filings' category serves as the fallback for miscellaneous filings that do not fit into other specific categories, and this is a formal regulatory report, 'RNS' is the most appropriate classification.
2025-11-17 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing a regulatory update (DEA forwarding a psilocybin rescheduling petition to HHS). It contains no financial results, no meeting materials, no share transactions or board changes, and is not the release of any periodic report or filing. It is thus a general regulatory announcement that does not fit other specific categories, making it a Regulatory Filing (RNS).
2025-08-20 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing the CEO’s invitation to speak at a conference and a live Q&A session for audited year-end results. It does not present full financial statements, earnings highlights, or detailed management discussion, nor does it announce a shareholder vote, capital change, or regulatory filing under a specific SEC or other form. This is a general announcement/press release and does not fit any more specific category, so it falls under Regulatory Filings (RNS).
2025-07-30 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release announcing the company’s audited annual consolidated financial statements and MD&A for the fiscal year ended March 31, 2025. It provides key financial highlights, CEO commentary, strategic achievements, and operational updates, and invites investors to a Q&A session. It is not the full annual report (which is available on the company’s website and SEDAR+); instead it serves as the initial announcement of year-end results—i.e., an Earnings Release. Therefore, it should be classified as ER. FY 2025
2025-07-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.